Authors:
Albrecht, MA
Bosch, RJ
Hammer, SM
Liou, SH
Kessler, H
Para, MF
Eron, J
Valdez, H
Dehlinger, M
Katzenstein, DA
Citation: Ma. Albrecht et al., Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection., N ENG J MED, 345(6), 2001, pp. 398-407
Authors:
Gunthard, HF
Havlir, DV
Fiscus, S
Zhang, ZQ
Eron, J
Mellors, J
Gulick, R
Frost, SDW
Brown, AJL
Schleif, W
Valentine, F
Jonas, L
Meibohm, A
Ignacio, CC
Isaacs, R
Gamagami, R
Emini, E
Haase, A
Richman, DD
Wong, JK
Citation: Hf. Gunthard et al., Residual human immunodeficiency virus (HIV) type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years, J INFEC DIS, 183(9), 2001, pp. 1318-1327
Authors:
Babiker, A
Bartlett, J
Breckenridge, A
Collins, G
Coombs, R
Cooper, D
Creagh, T
Cross, A
Daniels, M
Darbyshire, J
Dawson, D
DeGruttola, V
DeMasi, R
Dolin, R
Eron, J
Fischl, M
Grossberg, S
Hamilton, J
Hammer, S
Hartigan, P
Henry, K
Hill, A
Hughes, M
Kahn, J
Katlama, C
Katzenstein, D
Kim, S
Mildvan, D
Montaner, J
Moore, M
Neaton, J
O'Brien, W
Ribaudo, H
Richman, D
Saag, M
Salgo, M
Saravolatz, L
Schooley, R
Seligmann, M
Staszewski, S
Struthers, L
Tierney, C
Tsiatis, A
Welles, S
Citation: A. Babiker et al., Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis, AIDS RES H, 16(12), 2000, pp. 1123-1133
Citation: R. Swanstrom et J. Eron, Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance (vol 86, pg 145, 2000), PHARM THERA, 88(1), 2000, pp. 91-91
Authors:
Betts, MR
Krowka, JF
Kepler, TB
Davidian, M
Christopherson, C
Kwok, S
Louie, L
Eron, J
Sheppard, H
Frelinger, JA
Citation: Mr. Betts et al., Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors, AIDS RES H, 15(13), 1999, pp. 1219-1228